- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 317/64 - Atomes d'oxygène
Détention brevets de la classe C07D 317/64
Brevets de cette classe: 106
Historique des publications depuis 10 ans
|
3
|
11
|
13
|
15
|
8
|
8
|
4
|
7
|
4
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| ADT Pharmaceuticals, LLC | 12 |
8 |
| Xwpharma Ltd. | 60 |
6 |
| Abbvie Inc. | 1827 |
4 |
| JSR Corporation | 2545 |
4 |
| University of Ottawa | 223 |
4 |
| Calico Life Sciences LLC | 104 |
4 |
| Tasly Pharmaceutical Group Co., Ltd. | 119 |
3 |
| BASF SE | 21134 |
2 |
| BASF Corporation | 1695 |
2 |
| Firmenich SA | 1723 |
2 |
| Godavari Biorefineries Limited | 40 |
2 |
| Korea University Research and Business Foundation | 3121 |
2 |
| Kyungpook National University Industry-Academic Cooperation Foundation | 1190 |
2 |
| NATCO Pharma Limited | 203 |
2 |
| NHWA Pharma. Corporation | 50 |
2 |
| Ottawa Hospital Research Institute | 112 |
2 |
| Shijiazhuang Chengzhi Yonghua Display Material Co., Ltd. | 200 |
2 |
| Tohoku University | 2873 |
2 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2945 |
2 |
| University of Kansas | 899 |
2 |
| Autres propriétaires | 47 |